News

Press Release

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

Mabwell’s Subsidiary Myvision Appears at Retina China 2026

Highlights in Oral Presentation of Mabwell's 9MW2821 at 2026 ASCO

Press Conference on Early Diagnosis and Clinical Translation of Parkinson’s Disease & SST001 Clinical Trial Initiation Meeting Successfully Held

Mabwell Announces First Patient Dosing in Phase III Study of Bulumtatug Fuvedotin in TNBC Patients

Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations

Mabwell Announces NMPA Approval of Supplemental Application for Additional Indications of MAIWEIJIAN (Denosumab Injection)

Mabwell to Present Two Clinical Study Results as Oral Presentation at Retina China 2026

Mabwell’s 9MW5211 Receives FDA Clearance for Clinical Trial Application

2026 WOC | Mabwell to Present Latest Clinical Data on 9MW0211 for nAMD in Poster Presentations

2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations

1 2 3 Next